Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers develop new approach for studying HBV in the lab

Hepatitis C and hepatitis B viruses both attack the liver, eventually causing deadly cirrhosis or cancer. But while antivirals can cure 95 percent of HCV infections, its cousin HBV has long eluded effective therapeutics.

13 Apr 2023

HIV diagnoses increases more than three-fold after implementing targeted testing in EDs

Targeted testing for HIV in emergency departments has great potential for increasing diagnoses, this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (15-18 April), will hear.

10 Apr 2023

Does higher caffeine and coffee intake impact colonic microbiota composition and diversity?

Researchers investigated the association between caffeine and the colonic microbiome.

6 Apr 2023

What is currently known about the mechanisms by which DNA tumor viruses evade uracil-mediated antiviral immunity?

Researchers reviewed the existing knowledge on the mechanisms through which DNA tumor viruses evade the antiviral immunity mediated through mis-incorporated uracil (U).

3 Apr 2023

Study shows how many HBeAg-negative patients can achieve permanent immune control of hepatitis B

More than half of patients who suffer from chronic hepatitis B have the e antigen (HBeAg)-negative form of the disease.

30 Mar 2023

Lab-made antibodies may be able to cure people infected with yellow fever

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.

29 Mar 2023

Beethoven's cause of death revealed through DNA analysis of his hair

In a recent article published in the journal Current Biology, an international team of researchers sequenced the whole genome to high coverage from eight authenticated hair strands from Ludwig van Beethoven, one of the most influential European classical music composers born in 1770. He died on March 27, 1827.

27 Mar 2023

Tetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal model

In a recent study posted to the bioRxiv* preprint server, researchers in Italy and the United States evaluated the efficacy and immunogenicity of an adjuvanted tetravalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein subunit 1 (S1) COVID-19 vaccine.

21 Mar 2023

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV).

20 Mar 2023

How does chronic HBV infection affect flu and COVID-19 vaccine responses?

The influenza season marks the beginning of a time of illness, sometimes serious or even fatal, in much of the world. For this reason, flu shots are recommended, especially for individuals with underlying diseases such as chronic hepatitis B (CHB) infection, since they are at higher risk for adverse outcomes.

6 Mar 2023

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

Bone marrow is the spongy tissue inside bone responsible for making red blood cells, white blood cells and platelets. Bone marrow failure syndromes lead to an increased risk of developing dangerous infections, anemia and an increased risk of blood cancers.

2 Mar 2023

Pegylated interferon lambda shows good efficacy against COVID-19

In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.

9 Feb 2023

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Researchers investigated the B cell and humoral immune responses elicited against inactivated and recombinant SARS-CoV-2 vaccines and their safety profiles in patients with CKD.

8 Feb 2023

Study shows activation of pulmonary macrophages by SARS-CoV-2 spike glycoprotein

In a recent study published in the International Journal of Molecular Sciences, researchers investigated the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein on human lung macrophage (HLM) activation and angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) expression in human lung macrophages.

7 Feb 2023

Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers develop new approach for studying HBV in the lab

HIV diagnoses increases more than three-fold after implementing targeted testing in EDs

Does higher caffeine and coffee intake impact colonic microbiota composition and diversity?

What is currently known about the mechanisms by which DNA tumor viruses evade uracil-mediated antiviral immunity?

Study shows how many HBeAg-negative patients can achieve permanent immune control of hepatitis B

Lab-made antibodies may be able to cure people infected with yellow fever

Beethoven's cause of death revealed through DNA analysis of his hair

Tetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal model

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

How does chronic HBV infection affect flu and COVID-19 vaccine responses?

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

Pegylated interferon lambda shows good efficacy against COVID-19

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Study shows activation of pulmonary macrophages by SARS-CoV-2 spike glycoprotein

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

The impact of viral infections on the human endocrine system

Transcriptomics analysis identifies thousands of viroid-like circular RNA molecules

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Hepatitis B News and Research

Latest Hepatitis B News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in